Related Experiment Videos
[HLA A-B and DR in dilated myocardiopathies]
Insights
Dilated cardiomyopathy may be influenced by genetic factors. Specifically, the HLA DR4 antigen was significantly more frequent in patients, suggesting a role in the disease's immune response.
Area of Science:
- Immunogenetics
- Cardiology
- Autoimmunity
Context:
- Dilated cardiomyopathy (DCM) is a complex heart condition with potential immune system involvement.
- Understanding the genetic predisposition to DCM is crucial for identifying disease mechanisms.
Purpose:
- To investigate the association between human leukocyte antigen (HLA) genetic background and dilated cardiomyopathy.
- To determine if specific HLA antigens influence immune responses in DCM patients.
Summary:
- Human leukocyte antigen (HLA) A and B antigen frequencies did not differ between DCM patients and controls.
- However, HLA DR4 antigen frequency was significantly higher in DCM patients (40.8%) compared to controls (23.8%, p<0.001).
- This suggests a genetic susceptibility to DCM, potentially involving immune system modulation.
Impact:
- The findings indicate that genetic factors, particularly HLA DR4, may play a role in the pathogenesis of dilated cardiomyopathy.
- This association suggests that an altered immune response could be implicated in DCM development.
- Further research into HLA associations may reveal new diagnostic or therapeutic targets for DCM.
Abstract:
HLA A, B typing was performed in 90 patients (90 men, 10 women), and HLA DR typing in 49 patients with dilated cardiomyopathy in order to test the hypothesis that a particular genetic background may influence the immune response in that disease. No significant difference in phenotype frequency of the HLA A and B antigens was observed between patients and control population. In contrast, the HLA DR4 antigen was significantly more frequent among patients (40.8% vs 23.8%, p corrected less than 0.001). The results suggest that genetic factors play a role in the pathogenesis of dilated cardiomyopathy, and that since DR4 is frequently associated with auto-immune manifestations, a modified immune response is possible in dilated cardiomyopathy.